Dependency of the [18F]fluoromisonidazole uptake on oxygen delivery and tissue oxygenation in the porcine liver

Nuclear Medicine and Biology

Volumn 27, Issue 8, 2000, Pages 693-700

  Piert, Morand ^a   Machulla, Hans Jürgen ^a   Becker, Georg ^a   Aldinger, Peter ^a   Winter, Eugen ^b   Bares, Roland ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Hepatic oxygen delivery; Hepatic tissue oxygenation; Liver cell hypoxia; 18F fluoromisonidazole

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; MISONIDAZOLE; UNCLASSIFIED DRUG; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; DRUG DERIVATIVE; FLUORINE; MICROSPHERE; OXYGEN; RADIOPHARMACEUTICAL AGENT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; DRUG UPTAKE; FEMALE; LIVER ISCHEMIA; NONHUMAN; OXYGEN TRANSPORT; TISSUE OXYGENATION; VEIN BLOOD FLOW; ANIMAL; BLOOD; BLOOD GAS ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ELECTRODE; HEMODYNAMICS; LIVER; METABOLISM; OXYGEN CONSUMPTION; SCINTISCANNING; SWINE;

ANIMALS; BLOOD GAS ANALYSIS; ELECTRODES; FEMALE; FLUORINE RADIOISOTOPES; HEMODYNAMIC PROCESSES; LIVER; MICROSPHERES; MISONIDAZOLE; OXYGEN; OXYGEN CONSUMPTION; RADIOPHARMACEUTICALS; SWINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034353130     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(00)00151-7     Document Type: Article

References (55)

1. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo
2. Splanchnic oxygen consumption in septic and hemorrhagic shock
3. Hepatic splanchnic function in acutely hypoxemic humans at rest
4. Distribution of portal blood flow in the liver of the rat: A microsphere study
5. Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia
6. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data
7. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells
8. 3H-labelled misonidazole in the tumor-bearing mouse
9. Autoradiographic study of tritium-labeled misonidazole in the mouse
10. Arteriovenous anastomotic blood flow in the mesenteric organs
11. 18F]fluoromisonidazole and positron emission tomography (PET)
12. 15O]CO positron emission tomography (PET)
13. Misonidazole and other hypoxia markers: Metabolism and applications
14. Studies of portal hemodynamics and hepatic oxygen consumption during acute liver allograft rejection
15. The effect of halothane, isoflurane, blood loss on hepatotoxicity and hepatic oxygen availability in phenobarbital-pretreated hypoxic rats
16. Comparison of the effects of hepatic nerve stimulation on arterial flow, distribution of arterial and portal flows and blood content in the livers of anaesthetized cats and dogs
17. Intrahepatic distribution of portal and hepatic arterial blood flows in anaesthetized cats and dogs and the effects of portal occlusion, raised venous pressure and histamine
18. A radiosynthesis of fluorine-18 fluoromisonidazole
19. Injection-corrosion studies of normal and cirrhotic livers
20. Blood flow measurements with radionuclide-labeled particles
21. 3H]misonidazole in cerebral ischemia
22. 2 gradients from hemoglobin to cytochrome: New concepts, new complexities
23. Studies on the action of nitroimidazole drugs. The products of nitroimidazoles in a radiolytic model system
24. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F18]fluoromisonidazole positron emission tomography
25. Dopamine compensates for deterioration of hepatic hemodynamics and metabolism during occlusion and reperfusion of the hepatic artery
26. Method for measuring hepatic uptake of oxygen or other blood-borne substances in situ
27. 2+ and mitochondrial membrane potential preceding cell death in hepatocytes
28. Intrahepatic distribution of hepatic blood flow: Double-input studies
29. Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole
30. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis
31. 3H]fluoromisonidazole in ischemic myocardium
32. Fluoromisonidazole: A metabolic marker of myocyte hypoxia
33. Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia
34. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection
35. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver
36. The terminal distribution of the hepatic artery with special reference to arterio-portal anastomosis
37. Application of venous saturation monitoring
38. Effects of acute normovolemic hemodilution on splanchnic oxygenation and on hepatic histology and metabolism in anesthetized pigs
39. Nitroimidazoles and imaging hypoxia
40. The role of the abdominal sympathetic nervous system in regulating portal venous flow and its functional distribution
41. Analyse der leberhamodynamik beim schweren ischamie- und reperfusionsschaden nach lebertransplantation
42. Hepatic and splanchnic metabolism of plasma proteolytic enzymes before, during, and after clamping of the hepatic artery and portal vein
43. 18F]misonidazole and PET
44. Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia
45. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro
46. Retransplantation of the liver
47. Myocardial kinetics of fluorine-18 misonidazole: A marker of hypoxic myocardium
48. In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: A potential approach for identification of jeopardized myocardium
49. 18F]FMISO on different reaction parameters
50. Metabolic consequences of a reversed pH gradient in rat tumors
51. Hemodynamic effects on determinants of bile secretion in isolated rat liver
52. 2?
53. The biological properties of reduced nitroheterocyclies and possible underlying biochemical mechanisms
54. Hypoxia: An Introduction
55. Methodological error and spatial variability of organ blood flow measurements using radiolabeled microspheres